FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Special 510(k) Program Draft Guidance

Federal Register notice: FDA issues a draft guidance entitled The Special 510(k) Program.

Federal Register

FDA Debars Richard Fleming Due to Fraud Probe

Federal Register notice: FDA issues an order to debar Richard M. Fleming for 10 years from providing services in any capacity to a person that has an ...

Human Drugs

PET Drug CGMP Violations at N-Molecular

FDA warns N-Molecular about CGMP violations in its production of PET drugs.

Human Drugs

Guide on Atopic Dermatitis Pediatric Studies

FDA posts a guidance entitled Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs.

Human Drugs

Package Type Guidance

FDA issues a guidance with recommendations for selection of appropriate package type terms and appropriate discard statements for some drug, biologic,...

Human Drugs

Optimize Emergency Trial Pathway for Public Trust: Study

Researchers suggest a change in FDA reporting requirements for exception from informed consent clinical trials to better describe issues involving con...

Human Drugs

Amerisource Bergen Settles Cancer Drug Charges for $625 Million

The Justice Department says Amerisource Bergen is paying $625 million to resolve three whistleblower suits claiming that it operated a cancer supporti...

FDA General

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that include Datascope Corp. and Sofie Biosciences.

Medical Devices

Acessa Health Fibroid Device Cleared

FDA clears an Acessa Health 510(k) for the Acessa ProVu System, an integrated radiofrequency ablation, ultrasound visualization, and guidance mapping ...

Human Drugs

Endo Recalls Robaxin Due to Labeling Error

Endo International recalls two lots of Robaxin (methocarbamol tablets, USP) 750mg tablets in 100-count bottle packs due to some products having incorr...